Views & Analysis
Digital/ Oncology/ Views & Analysis/ Views & Analysis/ Views and analysis
AI providing the edge against cancer?
mike.hammerton@pharmaphorum.com
AI, AION, cancer diagnosis, clinical trials
0 Comment
Market Access/ Oncology/ Patients/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis
Regulation optimisation could save thousands of life years
Amanda Barrell
cancer, digital, Oncology, regulation
0 Comment
Oncology/ Podcast/ Video/ Views & Analysis/ Views and analysis
Merck on trends in oncology: the pharmaphorum podcast
Oncology/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand
Oncology treatment decisions aren’t just based on clinical data
mike.hammerton@pharmaphorum.com
Brand marketing, cancer immunotherapy, Cerner Enviza, oncology research
0 Comment
Oncology/ Views & Analysis/ Views and analysis
Using bispecific antibodies to advance cancer immunotherapy
mike.hammerton@pharmaphorum.com
cancer, immunotherapy
0 Comment
Oncology/ Views & Analysis/ Views and analysis
Blood Cancer UK: Hopes for our community’s future in the time of COVID
Kate Keightley
blood cancer, Blood Cancer UK, covid, Gilead, Kite, patients
0 Comment
Oncology/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers
How pharma can help the post-COVID recovery of European cancer care
mike.hammerton@pharmaphorum.com
Accord Healthcare, cancer, COVID-19, Oncology
0 Comment
Market Access/ Oncology/ Views & Analysis/ Views & Analysis/ Views and analysis